Preclinical biosafety studies of lentiviral vector-mediated gene therapy in erythrocyte pyruvate kinase deficiency

被引：0
|
作者：
Quintana-Bustamante, O. [1 ]
Sanchez-Dominguez, R. [1 ]
Garcia-Torralba, A. [1 ]
Alberquilla, O. [1 ]
Lopez-Manzaneda, S. [1 ]
Fananas, S. [1 ]
Nieto, V. [1 ]
Molinos, A. [1 ]
Garcia-Bravo, M. [1 ]
Yanez, R. [1 ]
Bueren, J. A. [1 ]
Navarro, S. [1 ]
Segovia, J. C. [1 ]
机构：
[1] FJD, IIS, CIBERER, CIEMAT, Madrid, Spain
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P031
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [41] Vector-mediated cancer gene therapy - An overview
    Seth, P
    CANCER BIOLOGY & THERAPY, 2005, 4 (05) : 512 - 517
  • [42] Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
    K Pike-Overzet
    M Rodijk
    Y-Y Ng
    M R M Baert
    C Lagresle-Peyrou
    A Schambach
    F Zhang
    R C Hoeben
    S Hacein-Bey-Abina
    A C Lankester
    R G M Bredius
    G J A Driessen
    A J Thrasher
    C Baum
    M Cavazzana-Calvo
    J J M van Dongen
    F J T Staal
    Leukemia, 2011, 25 : 1471 - 1483
  • [43] Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
    Pike-Overzet, K.
    Rodijk, M.
    Ng, Y-Y
    Baert, M. R. M.
    Lagresle-Peyrou, C.
    Schambach, A.
    Zhang, F.
    Hoeben, R. C.
    Hacein-Bey-Abina, S.
    Lankester, A. C.
    Bredius, R. G. M.
    Driessen, G. J. A.
    Thrasher, A. J.
    Baum, C.
    Cavazzana-Calvo, M.
    van Dongen, J. J. M.
    Staal, F. J. T.
    LEUKEMIA, 2011, 25 (09) : 1471 - 1483
  • [44] Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy
    Capowski, Elizabeth E.
    Schneider, Bernard L.
    Ebert, Allison D.
    Seehus, Corey R.
    Szulc, Jolanta
    Zufferey, Romain
    Aebischer, Patrick
    Svendsen, Clive N.
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 163 (02) : 338 - 349
  • [45] Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I
    Leon-Rico, Diego
    Aldea, Montserrat
    Sanchez-Baltasar, Raquel
    Mesa-Nunez, Cristina
    Record, Julien
    Burns, Siobhan O.
    Santilli, Giorgia
    Thrasher, Adrian J.
    Bueren, Juan A.
    Almarza, Elena
    HUMAN GENE THERAPY, 2016, 27 (09) : 668 - 678
  • [46] Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
    Johnson, LG
    Olsen, JC
    Naldini, L
    Boucher, RC
    GENE THERAPY, 2000, 7 (07) : 568 - 574
  • [47] Cytotoxicity Associated with Artemis Overexpression After Lentiviral Vector-Mediated Gene Transfer
    Multhaup, Megan
    Karlen, Andrea D.
    Swanson, Debra L.
    Wilber, Andrew
    Somia, Nikunj V.
    Cowan, Morton J.
    McIvor, R. Scott
    HUMAN GENE THERAPY, 2010, 21 (07) : 865 - 875
  • [48] Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
    Dreyer, Jean-Luc
    MOLECULAR BIOTECHNOLOGY, 2011, 47 (02) : 169 - 187
  • [49] Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer
    Villani, GRD
    Follenzi, A
    Vanacore, B
    di Domenico, C
    Naldini, L
    di Natale, P
    BIOCHEMICAL JOURNAL, 2002, 364 (03) : 747 - 753
  • [50] Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
    L G Johnson
    J C Olsen
    L Naldini
    R C Boucher
    Gene Therapy, 2000, 7 : 568 - 574
12345